Cox regression analysis revealed that chemotherapy and higher expression levels of TOP2A, HER2 and Ki67 were independent predictors of RFS in early-stage IBC patients with HR<sup>+</sup>. The gene discussed is MKI67; the disease is inflammatory breast carcinoma.